Human IL4/BCGF-1/BCGF1 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_000589)
Cat. No.: pGMAAV000365
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IL4/BCGF-1/BCGF1 Adeno-associated virus expression plasmid (ITR-vector) for IL4 AAV packaging, IL4 AAV production.The purified Human IL4/BCGF-1/BCGF1 AAV particle serves as an invaluable asset for in-depth in vivo IL4 studies, mechanism of action (MOA) research, and the evolution of IL4-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Go to
IL-4/IL4/IL4/BCGF-1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAAV000365 |
| Gene Name | IL4 |
| Accession Number | NM_000589 |
| Gene ID | 3565 |
| Species | Human |
| Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
| Insert Length | 462 bp |
| Gene Alias | BCGF-1,BCGF1,BSF-1,BSF1,IL-4 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | Null |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGGTCTCACCTCCCAACTGCTTCCCCCTCTGTTCTTCCTGCTAGCATGTGCCGGCAACTTTGTCCACGGACACAAGTGCGATATCACCTTACAGGAGATCATCAAAACTTTGAACAGCCTCACAGAGCAGAAGACTCTGTGCACCGAGTTGACCGTAACAGACATCTTTGCTGCCTCCAAGAACACAACTGAGAAGGAAACCTTCTGCAGGGCTGCGACTGTGCTCCGGCAGTTCTACAGCCACCATGAGAAGGACACTCGCTGCCTGGGTGCGACTGCACAGCAGTTCCACAGGCACAAGCAGCTGATCCGATTCCTGAAACGGCTCGACAGGAACCTCTGGGGCCTGGCGGGCTTGAATTCCTGTCCTGTGAAGGAAGCCAACCAGAGTACGTTGGAAAACTTCTTGGAAAGGCTAAAGACGATCATGAGAGAGAAATATTCAAAGTGTTCGAGCTGA |
| ORF Protein Sequence | MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-T00239 |
| Target Name | IL-4/IL4 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3565 |
| Gene ID |
100034225 (Equus caballus), 16189 (Mus musculus), 280824 (Bos taurus), 287287 (Rattus norvegicus) 3565 (Homo sapiens), 403785 (Canis lupus familiaris), 574281 (Macaca mulatta), 751514 (Felis catus) |
| Gene Symbols & Synonyms | IL4,Il4,IL-4,BSF-1,Il-4,Il4e12,BSF1,BCGF1,BCGF-1 |
| Target Alternative Names | B-cell stimulatory factor 1 (BSF-1),BCGF-1,BCGF1,BSF-1,BSF1,Binetrakin,IL-4,IL4,Il-4,Il4,Il4e12,Interleukin-4,Lymphocyte stimulatory factor 1,Pitrakinra |
| Uniprot Accession |
O77762,P05112,P07750,P20096,P30367,P42202,P51492,P55030
Additional SwissProt Accessions: P42202,P07750,P30367,P20096,P05112,O77762,P51492,P55030 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, INN Index |
| Disease | cancer, Breast Cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Leishmaniasis, Pathways in cancer, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Allograft rejection |
| Gene Ensembl | ENSECAG00000008299, ENSMUSG00000000869, ENSBTAG00000015957, ENSG00000113520, ENSCAFG00845010991, ENSMMUG00000003133 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


